Eisai Inc.

Form 483 issued July 22, 2016 · Baltimore, Maryland

Inspection
Jul 18 – Jul 22, 2016
Investigators
Eric L. Dong· Qin Xu
Observations
4
Pages
5
FEI number
1000158705

In short: On July 22, 2016, FDA issued a Form 483 with 4 observations to Eisai Inc. in Baltimore, Maryland (FEI 1000158705) after an inspection that ran Jul 18 – Jul 22, 2016. The investigators were Eric L. Dong and Qin Xu. Most observations concern laboratory controls and quality system.

At a glance

Laboratory controls and quality system account for 3 of 4 observations.

Laboratory controls2
Quality system1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Investigations of an unexplained discrepancy did not extend to other batches of…

  2. 02

    Established test procedures and laboratory control…

  3. 03

    Laboratory records do not include complete data derived from all tests, examinations and assay necessary to…

  4. 04

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Eisai Inc.?

FDA listed 4 observations on this Form 483, mostly about laboratory controls, quality system and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Eisai Inc.?

Eric L. Dong and Qin Xu are named on this Form 483, for the inspection of Jul 18 – Jul 22, 2016. Each investigator has a profile showing what they cite most.

When was Eisai Inc. inspected by FDA?

The inspection ran Jul 18 – Jul 22, 2016, and the Form 483 is dated July 22, 2016.

How do I get the full Form 483 for Eisai Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free